Company Filing History:
Years Active: 2012-2015
Title: Mohammed Sajad: Innovator in Respiratory Disease Treatment
Introduction
Mohammed Sajad is a notable inventor based in Essex, GB, recognized for his contributions to the field of respiratory disease treatment. With a total of three patents to his name, Sajad has made significant strides in developing pharmaceutical compositions aimed at improving pulmonary administration.
Latest Patents
Sajad's latest patents focus on innovative treatments for respiratory diseases. One of his key inventions describes a pharmaceutical composition adapted for pulmonary administration by inhalation. This composition comprises a glitazone, such as pioglitazone or rosiglitazone, along with one or more pharmaceutically acceptable carriers and/or excipients. The glitazone content of this composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. Additionally, the glitazone is presented in the form of microparticles, enhancing its efficacy in treating respiratory conditions.
Another patent by Sajad also provides a pharmaceutical composition for pulmonary administration, emphasizing the same glitazone components and their specific enantiomeric ratios. This innovation not only highlights Sajad's expertise but also his commitment to advancing treatment options for patients suffering from respiratory diseases.
Career Highlights
Throughout his career, Mohammed Sajad has worked with Pulmagen Therapeutics Limited and Pulmagen Therapeutics (inflammation) Limited. His work in these companies has been pivotal in the development of new therapeutic strategies for respiratory ailments.
Collaborations
Sajad has collaborated with notable professionals in his field, including Harry Finch and Craig Fox. These partnerships have contributed to the successful development and implementation of his innovative ideas.
Conclusion
In summary, Mohammed Sajad is a distinguished inventor whose work in respiratory disease treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his dedication to advancing medical science and improving health outcomes.